
The Benefits of Nattokinase with NSK-SD®
Key Takeaways
- Understand the research and rigorous testing that support the quality and identity of NSK-SD®.
- Learn how NSK-SD® may play a role in supporting women’s cardiovascular health.
Vincent Hackel, President & CEO of JBSL-USA, shares how NSK-SD® sets the standard in nattokinase science—from research and manufacturing to global opportunities in women’s heart-health innovation.
Sponsored by JBSL-USA
In this interview, Vincent Hackel, President and CEO of JBSL-USA, explores the science and innovation behind NSK-SD®, a nattokinase enzyme derived from non-GMO soybeans and backed by a growing body of clinical research. He explains how JBSL’s proprietary manufacturing process and decades of study distinguish NSK-SD® from other nattokinase ingredients. Hackel also touches on the enzyme’s potential relevance to cardiovascular wellness—including women’s heart health—along with opportunities for product developers to incorporate NSK-SD® into retail formulations. He concludes with a look at the global regulatory landscape and the expanding international demand for clinically supported cardiovascular ingredients.
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





